Novo Nordisk CEO Mike Doustdar particulars the corporate’s Amazon partnership, advantages of Ozempic past weight reduction and extra on ‘The Claman Countdown.’
Novo Nordisk’s oral variations of its blockbuster weight-loss medication, Ozempic and Wegovy, at the moment are out there for same-day supply on Amazon.
Novo Nordisk CEO Mike Doustdar stated on “The Claman Countdown” Friday the once-daily tablet variations of the corporate’s extremely well-liked therapies have been a serious success.
“It’s an thrilling time, I’d say, for the sufferers that may get entry to those merchandise when they need it and as quick as potential,” he informed FOX Enterprise.
“I feel it is very nice that, proper now, folks can have each Ozempic injection, in addition to Ozempic tablet.”
FIRST GLP-1 PILL FOR WEIGHT LOSS, DIABETES SHOWS SUCCESS IN LATE-PHASE TRIAL
Amazon is now providing same-day supply of Novo Nordisk’s Ozempic tablet. (Left (Justin Sullivan/Getty Photos), Proper (Michael Siluk/UCG/Common Photos Group by way of Getty Photos) / Getty Photos)
The Ozempic tablet launched final week, following the January debut of an oral model of Wegovy, which has delivered sturdy outcomes, producing greater than $350 million in first-quarter gross sales.
“This has been the perfect product launch within the final decade that we’ve seen. And I am extremely excited,” Doustdar stated. “Now we have seen in 16 weeks time, since we’ve launched it, a couple of million sufferers [who] have tried it.”
Ozempic is prescribed for sufferers with Kind 2 Diabetes, whereas Wegovy is used to deal with weight problems. Each therapies have been initially made as weekly injectables, however the newer oral variations are a once-daily tablet.
HHS SEC ROBERT F KENNEDY JR: AMERICAN PATIENTS PAY MORE SO OTHERS CAN PAY LESS — THAT STOPS NOW
“I’d say Wegovy’s tablet would be the one which would be the flagship, however the Ozempic tablet on the again of an iconic model identify, after all, will even discover its good area,” Doustdar stated.
Mike Doustdar, chief government officer of Novo Nordisk A/S, on the Novo Nordisk A/S annual common assembly in Copenhagen, Denmark, on Thursday, March 26, 2026. (Nichlas Pollier/Bloomberg by way of Getty Photos / Getty Photos)
Novo Nordisk was one of many first to work with the Trump administration to decrease the prices of pharmaceuticals and Doustdar stated decreasing costs was necessary to make sure truthful entry.
“We have been very blissful that we have been in a position to make a take care of the Trump administration, and primarily as a result of our job is to essentially make it possible for these modern drugs get entry, they usually do not turn into a product only for the wealthy. They turn into the product for everybody,” the CEO stated.
“I’d say decrease costs have supplied us with extra sufferers and extra quantity. Whereas quick time period, that is hurting our enterprise. Long run, it is the precise factor to do.”
Whereas Ozempic and Wegovy are identified for inducing weight reduction, Doustdar highlighted the medication’ broader advantages for cardiovascular, kidney and liver well being – most notably, their potential to treatment scarring in sufferers with fatty liver illness.
Photograph illustration of injectable prescription weight reduction drugs Ozempic on a weight scale. (Photograph by: Michael Siluk/UCG/Common Photos Group by way of Getty Photos) (Michael Siluk/UCG/Common Photos Group by way of Getty Photos) / Getty Photos)
CLICK HERE TO DOWNLOAD THE FOX NEWS APP
He additionally teased the potential launch of a brand new drug remedy that proves so efficient for liver illness that it may cut back the necessity for liver transplants.
“Now we have to complete the medical improvement of it, we’ve to get it accepted. But when the early information holds, then I am very optimistic,” Doustdar stated.
